CENTENE CORP
Close on Oct 19, 2026
- Market cap
- $34.15B
- P/E (TTM)
- –
- Dividend yield
- –
About Centene
Hospital & Medical Service Plans, SIC 6324
Centene Corporation is a managed healthcare enterprise that delivers health insurance and specialized clinical solutions primarily to underinsured and low-income populations. Operating across Medicaid, Medicare, Commercial, and Other business lines, the company provides government-sponsored programs including Medicaid expansion, Temporary Assistance for Needy Families, and Children’s Health Insurance Programs. It also delivers Medicare Advantage, Medicare Part D prescription drug coverage, and individual marketplace health insurance plans. Supplementary services include specialty pharmacy administration, behavioral health, dental, vision, and outpatient primary care. Centene serves low-income families, elderly individuals, individuals with disabilities, and commercial health insurance customers.
The company maintains an extensive domestic presence across the United States, managing health programs in multiple states and regions. It administers Medicaid services across 30 states, Medicare Advantage plans in 32 states, and individual marketplace insurance coverage throughout 29 states. In addition, its standalone prescription drug coverage extends across all 50 states and the District of Columbia. The enterprise operates through a decentralized community-focused model supported by a national corporate infrastructure. Centene does not specify its corporate headquarters city in the provided text.
Summary of the business section of Centene's latest annual report, written by StockData.
Company profile
Company
- Legal name
- CENTENE CORP
- Founded
- 1984
- Headquarters
- St Louis, MO
- Address
- 7700 Forsyth Blvd. 63105
- Phone
- (314) 725-4477
- Website
- www.centene.com
- Employees
- 61,100, Dec 31, 2025
- Industry
- Hospital & Medical Service Plans
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- KPMG LLP, St. Louis, MO
Stock & identifiers
- Ticker
- CNC
- Exchange
- NYSE
- IPO date
- Aug 8, 2003
- Shares outstanding
- 494M, Jul 24, 2026
- Public float
- $26.70B, Jun 30, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 2-for-1, Feb 7, 2019; 2-for-1, Dec 12, 2018; 2-for-1, Feb 20, 2015; 2-for-1, Feb 2, 2015; 2-for-1, Dec 20, 2004; 3-for-2, Jul 14, 2003
- SEC CIK
- 1071739
- CUSIP
- 15135B101
- ISIN
- US15135B1017
- LEI
- 549300Z7JJ4TQSQGT333
- EIN
- 04-1406317
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Sarah London | Chief Executive Officer, Director | 1,188,831 |
| Theodore J. Pienkos | Corporate Controller & CAO | 28,751 |
| Christopher Koster | Secretary & General Counsel | 248,954 |
| Susan Raye Smith | Chief Operating Officer | 212,237 |
| Michael A. Carson | Group President, Medicare&Spec | 123,707 |
| Daniel P. Finke | Group President, Markets&Comm | 228,127 |
| Tanya M. McNally | Chief People Officer | 127,258 |
| Andrew Lynn Asher | Chief Financial Officer | 747,989 |
| Katie Casso | Corporate Controller & CAO | 109,776 |
| Lauren M. Tyler | Director | 3,698 |
| Christopher J. Coughlin | Director | 49,348 |
| Kenneth Tanji | Director | 13,093 |
| Frederick H. Eppinger | Director | 370,402 |
| Theodore R. Samuels II | Director | 57,796 |
| Paul J. Diaz | Director | 0 |
| Kenneth A. Burdick | Director | 283,584 |
| Jessica L. Blume | Director | 32,607 |
| H. James Dallas | Director | 49,567 |
| Monte E. Ford | Director | 14,827 |
| Wayne S. DeVeydt | Director | 19,523 |
| Thomas Greco | Director | 22,888 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $19.51M | $4.65M | $7.66M | $69 | $148 |
| FY2025 London | $19.51M | $4.65M | $7.66M | $69 | $148 |
| FY2025 Neidorff | $0 | $0 | $7.66M | $69 | $148 |
| FY2024 | $20.60M | $5.38M | $7.20M | $101 | $129 |
| FY2024 London | $20.60M | $5.38M | $7.20M | $101 | $129 |
| FY2024 Neidorff | $0 | $0 | $7.20M | $101 | $129 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had approximately 61,100 team members.”
Corporate history
Events identified from SEC filings